Kieran O'Kane, Chief Commercial Officer at BIODESIX INC (BDSX), sold 25 shares at $7.62 ($191) on 2025-11-10, disclosed to the SEC on 2025-11-13.
Seasonal sale ($190) by Chief Commercial Officer — this insider has traded BDSX in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BDSX | SELL | 2026-01-20 | $2K | — | Filing → |
| BDSX | SELL | 2025-08-14 | $200 | — | Filing → |
| BDSX | SELL | 2025-05-13 | $169 | — | Filing → |